Orforglipron
A Study of Orforglipron (LY3502970) in Adolescent Participants With Obesity, or Overweight With Related Comorbidities
Eli Lilly · Phase 3 · Recruiting · Enrollment 150
No selected arm has a reported week for this endpoint.
A solid line connects the weeks the source reports.